SEARCH

SEARCH BY CITATION

References

  • 1
    Uchino J, Sato N, Nakajima T, Matsushita M, Takahashi M, Une Y. Treatment. In: UchinoJ, SatoN, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993: 137149.
  • 2
    Ammann RW, Ilitsch N, Marincek B, Freiburghaus AU, The Swiss Echinococcosis Study Group. Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Hepatology 1994; 19: 735742.
  • 3
    Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull WHO 1986; 64: 383388.
  • 4
    Brimblecombe RW. Eskazole (Albendazole) 400 mg Tablets-Part I: Expert Report on Clinical Document report by SmithKline Company March, 1989.
  • 5
    Wen H, Zou PF, Yang WG, Lu J, Wang YH, Zhang JH, New RRC, et al. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Trans R Soc Trop Med Hyg 1994; 88: 340343.
  • 6
    Rausch RL, Wilson JF, McMahon BJ, O'Gorman MA. Consequences of continuous mebendazole therapy in alveolar hydatid disease: with a summary of a ten-year clinical trial. Ann Trop Med Parasitol 1986; 80: 403419.
  • 7
    Sato N, Uchino J, Aoki S, Taguchi K, Nishikawa M, Baba E, Nakagawa T, et al. Efficacy of benzimidazole-type drugs on alveolar echinococcosis (AE). Jpn Soc Gastroenterol 1994; 91: 11971204.
  • 8
    Schantz PM, Van den Bosche H, Eckert J. Chemotherapy for larval echinococcosis in animals and humans: Report of a workshop. Z Parasitenkde 1982; 67: 526.
  • 9
    Wilson JF, Rausch RL, McMahon BJ, Schantz PM. Parasitocidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. Clin Infect Dis 1992; 15: 234249.
  • 10
    Nakajima Y, Sato N, Uchino J. Stage of the disease. In: UchinoJ, SatoN, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993: 115119.
  • 11
    Morris DL, Dykes PW, Dickson B, Marriner SE, Bogan JA, Burrows FGO. Albendazole in hydatid disease. Br J Med 1983; 286: 103104.
  • 12
    Morris DL, Skene-Smith H, Haynes A, Burrows FGO. Abdominal hydatid disease: complete tomographic and ultrasound changes during albendazole therapy. Clin Radiol 1984; 35: 297300.
  • 13
    Didier D, Weiler S, Rohmer P, Lassegue A, Deschamps JP, Vuitton D, Miguet JP, et al. Hepatic alveolar echinococcosis: correlative US and CT study. Radiology 1987; 154: 179186.
  • 14
    Liu YH, Wang XG, Chen YT, Yao YQ. Computer tomography of the liver in alveolar echinococcosis treated with albendazole. Trans R Soc Trop Med Hyg 1993; 87: 319321.
  • 15
    Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36: 576585.
  • 16
    Uchino J, Sato N. Prognosis. In: UchinoJ, SatoN, eds. Hokkaido University Medical Library Series. Vol 30. Sapporo, Japan: Kokoku Printing, 1993: 177179.
  • 17
    Mesarina B. Long-term course of alveolar echinococcosis in 70 patients treated by benzimidazole derivatives (1976-89) (Thesis). Zurich: University of Zurich, 1991: 22.
  • 18
    Ammann R, Hirsbrunner R, Cotting J, Steiger U, Jacquier P, Eckert J. Recurrence rate after discontinuation of long-term mebendazole. Am J Trop Med Hyg 1990; 43: 506515.
  • 19
    Schantz PM, Wilson JF, Wahlquist SP, Boss LP, Rausch RL. Serological tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multilocularis). Am J Trop Med Hyg 1983; 32: 13811386.